Azeltin

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Azeltin

Here is a summary of the foundational facts about this medication.

Property Description
Active ingredient Azithromycin (typically as the dihydrate form)
Form Film-coated Tablet, Capsule, Oral Suspension, Intravenous Injection
Pharmacological class Antibiotic (Macrolide / Azalide subclass)
Common use Fighting a wide variety of bacterial infections
Origin Semi-synthetic (derived from Erythromycin)

What Type of Medicine is Azeltin?

Azeltin is the trade name for a prescription-only anti-infective medication used to combat various bacterial infections. The drug is formally classified as a broad-spectrum antibiotic, belonging to the Macrolide group, and is more specifically categorized as an Azalide antibiotic subclass. Azeltin, which contains Azithromycin, is clinically recognized for its reliable efficacy against many common pathogens that cause infections such as bronchitis and certain skin infections.

The medication's active compound is Azithromycin, often administered in its stable form, Azithromycin dihydrate. Azithromycin is a key agent in the Macrolide group, demonstrating a unique ability to rapidly diffuse into tissues and sustain high local concentrations. This persistent presence in tissues means the medicine can continue to work against bacteria long after the last dose is taken.

Azeltin Composition and Pharmaceutical Forms

The core chemical compound in Azeltin is the active ingredient Azithromycin, supplied as a single-ingredient product formulated with pharmaceutical excipients. The substance is semi-synthetic, meaning it is chemically modified from the naturally occurring Erythromycin.

To facilitate different treatment needs, Azeltin is available in several key dosage form(s). These include the common Film-coated Tablet and Capsule, as well as the Oral Suspension (prepared from a Powder for Oral Suspension), making it suitable for both Adults and the Paediatric patient group. The primary route of administration is oral, but a parenteral Intravenous Injection form is also available for hospitalized patients, depending on the severity of the bacterial infection.

General Purpose: How Azeltin Fights Infection

The general purpose of Azeltin is to serve as an effective anti-infective agent to eliminate or control susceptible bacterial pathogens throughout the body. The drug works by focusing its anti-bacterial effects on the bacterial cell, specifically targeting the 50S ribosomal subunit to achieve the inhibition of bacterial protein synthesis.

The long half-life of Azithromycin enables a simplified, shorter duration of therapy for many types of infection. This indicates the drug is designed to remain active in the body for an extended time, often resulting in fewer doses needed overall. This property is a significant differentiating factor for the azalide subclass.

Regulatory References

  1. NIH MedlinePlus Monograph

What side effects are possible with Azeltin?

Possible Side Effects and Safety Information

The safety profile of Azeltin, which contains Azithromycin, is defined by regulatory agencies based on frequency classification and the system-organ class (SOC) affected. The most frequently reported adverse reactions are related to the gastrointestinal system.

Frequency-Classified Adverse Reactions

The official Summary of Product Characteristics (SmPC) classifies side effects based on how often they occur:

  • Very Common (Affects more than 1 in 10 patients): Diarrhea, abdominal pain, and nausea.
  • Common (Affects up to 1 in 10 patients): Headache, vomiting, and various changes in white blood cell counts.
  • Uncommon (Affects up to 1 in 100 patients): Palpitations, dizziness, nervousness, and rash.

Serious Adverse Reactions and Systemic Risks

Official labeling documents several serious adverse reactions. The drug is associated with potential risk to specific systems, notably the heart and liver. Serious reactions include QT interval prolongation, which can lead to a potentially fatal irregular heart rhythm known as Torsades de pointes. Cases of severe hepatotoxicity, including hepatic failure, and serious allergic reactions (such as Angioedema, Anaphylaxis, and Stevens-Johnson syndrome) are also documented.

Population-Specific Safety Constraints

Specific cautions and restrictions are defined for certain patient groups. Azeltin is formally contraindicated in patients with known severe hepatic impairment due to the risk of exacerbating liver damage. Caution is also noted for use in the elderly, who may be more susceptible to cardiac rhythm effects, and for neonates, where the risk of Infantile Hypertrophic Pyloric Stenosis (IHPS) has been reported.

Overdose and Emergency Response

Overdose and when to seek help for Azeltin (Azithromycin)

Overdosage with Azeltin is formally documented in regulatory prescribing information and primarily presents as an exaggeration of known adverse effects.

Documented Manifestations and Severe Risks

The most commonly reported manifestations of overdosage are severe gastrointestinal disturbances, including nausea, vomiting, diarrhea, and stomach discomfort. Overdose may also be associated with hearing change or loss.

Critically, overexposure carries a significant risk of life-threatening outcomes affecting the heart. Regulatory documents warn of the potential for prolongation of the QT interval and severe ventricular arrhythmias, such as Torsades de pointes, which can lead to cardiovascular death. Due to this risk, continuous ECG monitoring and hospital observation are generally required. Severe hepatic failure is also a documented concern.

Overdose Management Statement Status
Specific Antidote Known No
Primary Management Symptomatic and supportive measures are indicated

When Immediate Medical Help is Required

Seek immediate medical attention or contact emergency services immediately upon any suspected overdosage. Urgent medical help is necessary when severe symptoms are present, particularly if the patient experiences an irregular or rapid heartbeat, fainting, or difficulty breathing. Specific population considerations note that elderly patients face increased cardiac risks, and parents should monitor neonates for signs related to Infantile Hypertrophic Pyloric Stenosis (IHPS).

Therapeutic Uses of Azeltin

What Azeltin Treats: Main Uses and Benefits

Azeltin is generally applied across domains where additional symptomatic support is needed for conditions involving acute or disruptive symptom patterns. It is commonly used across conditions characterized by periods of heightened symptoms, such as those that cause symptoms related to physical discomfort and **systemic imbalance.

It is relevant for managing symptoms that interfere with daily comfort across therapeutic areas involving heightened responses, such as symptoms associated with acute or episodic changes in the respiratory tract, the skin and soft tissues, and genitourinary systems. In these acute contexts, it offers symptomatic relief that helps patients cope more steadily during difficult episodes.

“It provides support that helps ease the overall symptom burden in situations where additional management of discomfort is required.”

The medication is commonly used in clinical settings that involve acute or unstable symptom patterns for pediatric patients and other groups where functional stability becomes affected. It may be part of symptomatic management to address symptoms associated with acute or episodic changes in immune-compromised patients.

Quick Fact: Relief for Acute Symptom Clusters

Regulatory References

  1. NIH MedlinePlus overview on Azithromycin

Eligibility and Restrictions for Use

Who Can and Cannot Use Azeltin?

Azeltin (Azithromycin) eligibility is determined by specific regulatory guidelines regarding hypersensitivity, age, and pre-existing health conditions.

Contraindicated Populations

The medicine is contraindicated in patients with a known hypersensitivity to Azithromycin or any other Macrolide or Ketolide antibiotic. It is also prohibited for individuals with a history of cholestatic jaundice or hepatic dysfunction associated with prior Azithromycin use, as stated in official labeling.


Age and Condition Restrictions

Age Eligibility:

  • Use is generally not established for infants under six months of age.
  • Older adults (ge 65 years of age) may use Azeltin but require caution due to labeled increased susceptibility to Torsades de Pointes.

Condition-Based Restrictions:

  • Use is not recommended for patients with pre-existing conditions like prolongation of the QT interval, clinically significant bradycardia, or uncompensated heart failure.
  • Caution is required for patients with severe renal impairment (GFR < 10 mL/min) or severe hepatic impairment (Child-Pugh Class C), and use may be restricted or discouraged in these groups.

Pregnancy and Lactation:

  • Use during pregnancy and lactation is generally not recommended unless necessary and approved by a healthcare professional.

What should I know about interactions with other medicines?

Azeltin (azelastine) is generally considered to have fewer clinically significant drug-drug interactions compared to older generation antihistamines, however, caution is necessary, particularly with substances that also affect the central nervous system (CNS).

Central Nervous System (CNS) Depressants and Alcohol

The most important interactions involve medicines and products that cause drowsiness or sedation. Using Azeltin concurrently with these substances can lead to an additive or synergistic effect, increasing the risk of decreased alertness, severe drowsiness, and impaired cognitive function. Patients should avoid the concurrent use of alcohol while taking Azeltin.

Clinically significant moderate interactions that may increase CNS depression include, but are not limited to, the following drug classes:

Drug Class Examples Potential Effect
Benzodiazepines Lorazepam, Clonazepam Increased sedation and dizziness
Opioid Pain Relievers Codeine, Hydrocodone Increased sedation and respiratory depression
Sedating Antihistamines Diphenhydramine Increased drowsiness and CNS impairment
Certain Anticonvulsants Gabapentin, Pregabalin Increased sleepiness
Certain Antidepressants Trazodone, Amitriptyline Increased sedation

Metabolic Interactions

Azelastine and its metabolite, desmethylazelastine, are known to have a weak inhibitory effect on certain cytochrome P450 enzymes, particularly CYP2D6. The clinical significance of this inhibition is considered low with typical Azeltin dosing, but healthcare providers should still be informed of all medications being taken, especially those metabolized by CYP2D6, to monitor for any potential changes in drug concentration or effect.

Mechanism of Action

Azeltin's mechanism of action operates across three key biological domains, resulting in the interruption of bacterial growth and regulation of host pathways.

Molecular Inhibition of Bacterial Protein Synthesis

This domain explains the primary target and interaction: the drug directly binds to the 50S ribosomal subunit of susceptible bacteria, blocking the polypeptide exit tunnel and inhibiting the synthesis of essential proteins. This molecular blockade immediately prevents the bacterium from growing and reproducing, inducing a bacteriostatic effect.

Sustained Suppression and Intracellular Targeting

The mechanism is supported by the drug's ability to accumulate rapidly inside the body’s immune cells (phagocytes), which transport high concentrations of the active ingredient directly to the site of action. This unique localization and slow release lead to a Post-Antibiotic Effect (PAE), meaning the suppression of bacterial growth persists even after drug levels in the circulation decline, which facilitates host clearance mechanisms.

Regulation of Host Inflammatory Signaling

Azeltin also acts beyond the pathogen by engaging mechanisms that modulate the host immune system. Its activity helps to regulate the function and migration of inflammatory cells and influence the production of specific cytokines. This secondary action contributes to reducing excessive local inflammation, which modulates physiological activity associated with inflammation at the site of action.

Dosage and Administration Information

How Azeltin is Used

Azeltin (Azithromycin) is administered according to standardized regimens. The medicine is primarily used via the oral route, in the form of film-coated tablets, capsules, or oral suspension. An intravenous (IV) infusion form is also available for hospitalized patients, typically for initial, serious therapy, before transitioning to the oral form.

Regimen Pattern Oral Dosing Schedule (Adult) Duration
Standard 5-Day Course 500 mg on Day 1, then 250 mg once daily on Days 2–5. 5 days
Standard 3-Day Course 500 mg once daily. 3 days
Single-Dose 1000 mg (1 gram) as a single dose. 1 day

The drug is typically taken once daily, leveraging its long half-life to simplify the course duration. For the majority of oral forms (tablets and standard liquid), administration may occur with or without food. However, specific high-dose, single-use oral suspensions must be taken on an empty stomach (at least one hour before or two hours after a meal) to ensure proper systemic delivery.

When administered intravenously, the 500 mg dose must be prepared by reconstitution and dilution to a specific concentration and infused slowly over a period of 1 to 3 hours; it must never be given as a rapid injection. Dosing for pediatric patients is calculated based on body weight (mg/kg), while no dose adjustment is required for older adults or individuals with mild to moderate kidney impairment.

Recent Clinical Evidence

Research evidence / Overview of studies for Azeltin


Evidence for Upper and Lower Respiratory Tract Infections

Azeltin (Azithromycin) was evaluated in numerous Randomized Controlled Trials (RCTs) and systematic reviews to evaluate its use in research contexts involving common respiratory conditions, such as pneumonia, bronchitis, and ear/throat infections. The research primarily examined clinical resolution, used in research exploring how symptoms change over time, and the measured rate of bacterial eradication. Trials often compared Azithromycin’s shorter schedules against longer standard antibiotic courses.

For conditions like Community-Acquired Pneumonia (CAP), studies reported measurements of clinical stability and eradication rates. The findings describe patterns observed in the studies where short-term clinical outcomes were observed in the studied populations. However, long-term outcomes beyond the initial recovery period are not fully characterized, and data are still emerging regarding its use where antimicrobial resistance is highly prevalent.


Evidence for Uncomplicated Skin and Soft Tissue Infections

The evidence base for bacterial infections of the skin includes short-term comparative trials. These studies research examined the speed and extent of microbial clearance. The findings indicate patterns of successful short-term outcomes in studies involving otherwise healthy adults with non-severe, localized infections. It is important to note that the results apply only to the populations studied, which were typically uncomplicated cases that did not require additional procedures.


Evidence for Sexually Transmitted Infections (STIs)

Azeltin was evaluated in pivotal single-dose RCTs for specific, uncomplicated sexually transmitted infections. The research describes patterns where a single, high dose appears to be associated with measurements of microbial eradication. Evidence is limited for treating infections at non-genital anatomical sites, and the long-term effects are not fully established regarding the prevention of potential chronic complications.

Frequently Asked Questions (FAQ)

Common questions about Azeltin (FAQ)

Q: How quickly can a person generally expect to notice the effects of Azeltin?

Official information indicates that Azeltin begins acting quickly, achieving a bacteriostatic effect by stopping bacterial protein synthesis. The drug's unique mechanism involves its ability to accumulate in the body’s immune cells, allowing for sustained local concentrations at the site of infection. However, regulatory data focuses on these biological mechanisms and does not provide a specific timeframe for when a person might notice relief from their symptoms.


Q: Can Azeltin be taken by someone who has mild liver or kidney concerns?

According to the official product information, dose adjustment is typically not required for individuals who have mild to moderate kidney impairment. For liver concerns, the medication is contraindicated (prohibited) for those with severe hepatic impairment. The regulatory label notes caution is required for individuals with severe renal or pre-existing hepatic impairment.


Q: Is it true that Azeltin is only for short-term use?

Yes, Azeltin is described in official documents as being prescribed in short, standardized courses. Depending on the infection being treated, these regimens typically range from a single, one-day dose up to five days of use.


Q: Is there a specific age range or weight range that is covered by the research for Azeltin?

Clinical studies and regulatory guidelines cover a wide range of ages, from pediatric patients to older adults. For children, the appropriate amount of medicine is calculated based on their body weight (mg/kg). Official documents note increased susceptibility to cardiac rhythm effects in older adults.


Q: Why do people sometimes say Azeltin makes them feel 'groggy'?

Official product information reports certain central nervous system effects, such as dizziness, headache, and nervousness, as known side effects. These effects may contribute to a feeling of 'groggy' or decreased alertness. This is also increased if taken alongside certain other medications that cause drowsiness.


Q: Are there any dietary restrictions or foods to avoid when taking Azeltin?

For most of the oral forms, such as the standard film-coated tablets or suspension, the medicine may be taken with or without food. However, official regulatory documents indicate that specific high-dose, single-use oral suspensions must be taken on an empty stomach, as its absorption into the body may be affected by food.


Q: What happens if a person occasionally misses a dose of Azeltin?

Official regulatory patient information describes that if a dose is missed, it can be taken when it is remembered. Subsequent doses would then follow the prescribed schedule.


Q: Is Azeltin a drug that can be stopped suddenly?

Official guidance emphasizes that antibiotic treatment should be completed for the full prescribed duration to help prevent bacteria from becoming resistant to the medicine. Discontinuation is required only if serious adverse reactions, such as a severe allergic reaction, are experienced.


Q: Are there any long-term side effects that are commonly discussed in relation to Azeltin?

Since Azeltin is typically used in short courses, clinical trials and official data focus primarily on the short-term safety profile and outcomes immediately following use. Consequently, comprehensive information on possible adverse effects or outcomes extending far beyond the initial recovery period is less defined.


Q: Can Azeltin be taken if I am also taking over-the-counter pain relievers?

Official regulatory documents do not list common over-the-counter pain relievers, such as acetaminophen or ibuprofen, as having a specific or clinically significant interaction with Azeltin that requires monitoring or dose changes.


Q: Is Azeltin safe to take with common vitamins and supplements?

Regulatory guidance highlights the importance of discussing all products, including vitamins and herbal supplements, with a healthcare professional. Formal interaction studies are often not performed with these products, and checking for potential overlap with the drug's metabolism is noted.


Q: Can Azeltin affect one's ability to drive or operate machinery?

The official summary of product information notes that Azeltin is associated with certain side effects, including dizziness and nervousness, which could potentially impair one’s judgment or physical ability. This information is provided to allow for appropriate precaution.


Q: Can a person take Azeltin if they have a history of heart problems?

The official label advises that the medicine should be used with caution due to the risk of affecting the heart’s electrical activity (QT interval prolongation). Use is generally not recommended for people with a history of QT prolongation, clinically significant slow heart rate (bradycardia), or uncompensated heart failure.


Q: Is Azeltin generally considered safe for use in older adults?

The official label indicates that caution is noted for older adults. While the dosage is the same as for younger adults, this caution is due to a labeled increased susceptibility to the drug's potential effect on heart rhythm.


Q: Does Azeltin interfere with sleep patterns?

Uncommon side effects such as nervousness and dizziness have been reported. Furthermore, if Azeltin is taken alongside certain other medications, an increased feeling of sleepiness (somnolence) may occur.


Q: What is the general success rate or expectation for people using Azeltin?

Clinical trial data published in regulatory documents provides evidence of microbial eradication and clinical success rates for specific infections and study populations. The outcomes observed in trials may vary depending on the specific type and severity of the infection being addressed.


Q: Can a person drink coffee or caffeine while taking Azeltin?

Regulatory documents do not list caffeine or coffee as a substance with a specific, clinically significant interaction that requires monitoring or dose adjustment.


Q: Are there any known interactions with common cold and flu medications?

Cold and flu medicines can often contain multiple ingredients, some of which may cause drowsiness or affect heart rhythm. Official guidance states that caution is noted with medications that cause drowsiness, as this may lead to additive effects with Azeltin.


Q: Is Azeltin associated with any change in mood or feelings of anxiety?

Official regulatory documents list uncommon side effects that include nervousness and anxiety. In rare post-marketing reports, psychiatric reactions such as aggression and agitation have also been reported.


Q: Does Azeltin interact with blood thinners or anti-clotting medicines?

Yes, co-administration with oral anticoagulants, such as warfarin, may potentially increase the effect of the blood thinner. Official guidance indicates that close monitoring of blood clotting indicators may be necessary if these medicines are taken together.


Q: Is Azeltin classified as a controlled substance?

No, according to national drug classification systems, Azeltin (Azithromycin) is not classified as a controlled substance.


Q: Are there different strengths of Azeltin available?

Yes, Azeltin is available in various strengths across its multiple pharmaceutical forms, which include film-coated tablets, capsules, and powder for oral suspension.


Q: Can Azeltin affect the results of any common lab tests?

Yes, official adverse reaction reports include laboratory abnormalities such as changes in white blood cell counts. These changes have included decreases in lymphocytes and increases in eosinophils and basophils.


Q: Is there a specific time of day that is generally mentioned for taking Azeltin?

The prescribed regimen for Azeltin is typically once daily. Regulatory documents do not specify a general time of day (morning or evening) but emphasize consistency in the dosing schedule.


Q: Has Azeltin been studied in people with multiple other health conditions?

While clinical trials often exclude patients with serious, complicating conditions, the regulatory label details specific restrictions and caution for use in patients with pre-existing hepatic, renal, or cardiovascular conditions. This indicates that the drug's effects in people with other comorbidities have been analyzed.


Q: What is the total time it takes for Azeltin to leave the body after stopping?

Azeltin has a prolonged terminal elimination half-life of 68 hours, which is the time it takes for half the drug to be eliminated from the body. Due to this long half-life, the active ingredient can remain in the body’s tissues for an extended period after the last dose is taken.


Q: Are there any known interactions with herbal remedies like St. John's Wort?

Regulatory guidance highlights the importance of discussing all products, including herbal remedies, with a healthcare professional. Formal interaction studies are often not performed with these products.


Q: Is Azeltin used for prevention or only for treatment?

Azeltin is primarily approved for the treatment of various bacterial infections. However, official indications also include its use for prevention (prophylaxis) of certain infections, such as Mycobacterium avium complex disease, in specific patient populations.


Q: Is it normal to feel a bit tired or drowsy when first starting Azeltin?

Uncommon side effects such as dizziness and nervousness have been reported and may contribute to general tiredness. Increased sleepiness (somnolence) may also be experienced if Azeltin is taken in combination with certain other medications.

How should Azeltin be stored and disposed of?

How to Store and Dispose of Azeltin (Azithromycin)

The official storage requirements for Azeltin depend on the product form to maintain stability.

Product Form Required Storage Temperature Range
Tablets & Dry Powder Controlled Room Temperature (15 C to 30 C/ 59 F to 86 F)
Prepared Oral Suspension 5 C to 30 C (41 F to 86 F)

Storage must protect the suspension from freezing; specific formulations may also prohibit refrigeration. The prepared multi-day suspension must be discarded after 10 days of reconstitution, as specified in regulatory labeling. All forms of Azeltin must be stored out of the sight and reach of children. Unused or expired medicine, including any remaining suspension, must be disposed of in accordance with local regulations and generally should not be put into wastewater or household waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Azeltin found in:

A-Z Index: